Dallah Healthcare Company SJSC
SAU:4004
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
154.2
188
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Dallah Healthcare Company SJSC
Dallah Healthcare Company SJSC
Cash from Financing Activities
Dallah Healthcare Company SJSC
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Cash from Financing Activities
-ď·Ľ315.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
National Medical Care Company JSC
SAU:4005
|
Cash from Financing Activities
ď·Ľ34.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Cash from Financing Activities
-ď·Ľ450.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-27%
|
|
|
A
|
Al Hammadi Holding Co
SAU:4007
|
Cash from Financing Activities
-ď·Ľ257m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Cash from Financing Activities
ď·Ľ115.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Cash from Financing Activities
-ď·Ľ1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dallah Healthcare Company SJSC
Glance View
In the bustling heart of Saudi Arabia, Dallah Healthcare Company SJSC stands as a beacon of medical excellence and innovation, weaving a rich tapestry of healthcare services that cater to a diverse population. Founded in 1987, the company grew from its flagship Dallah Hospital in Riyadh, a state-of-the-art institution designed to meet international healthcare standards. Over the years, Dallah has meticulously expanded its reach, both in geographical scope and range of services, establishing itself as a pioneer in the Saudi healthcare sector. Its facilities are equipped with cutting-edge technology and staffed by highly skilled medical professionals who provide a wide array of services, from basic outpatient care to complex surgeries and specialized treatments. Fundamentally, Dallah Healthcare's business model revolves around offering comprehensive healthcare services that generate revenue primarily through patient fees. The company also capitalizes on its strategic partnerships and collaborations with insurance companies, enhancing its customer base by ensuring healthcare accessibility to insured patients. Additionally, Dallah invests in ancillary services like pharmacies and diagnostic centers, creating a robust network that offers integrated care solutions. This diversified approach not only ensures a steady flow of income but also positions Dallah as a key player in fulfilling the Kingdom’s vision for a healthier future, aligning with broader national health initiatives while continually striving to provide high-quality medical services.
See Also
What is Dallah Healthcare Company SJSC's Cash from Financing Activities?
Cash from Financing Activities
-315.6m
SAR
Based on the financial report for Sep 30, 2024, Dallah Healthcare Company SJSC's Cash from Financing Activities amounts to -315.6m SAR.
What is Dallah Healthcare Company SJSC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-40%
Over the last year, the Cash from Financing Activities growth was 42%.
You don't have any saved screeners yet